Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

Yale University · NCT02811510

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
40
US sites recruiting
1
Study start
June 2016
Record last updated
June 10, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Being studied: Placebo; Dronabinol

Conditions: Cannabis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • At least one lifetime exposure to cannabis
  • Good physical and mental health

Exclusion Criteria

  • Cannabis naive individuals
  • Major current or recent stressors
  • Taking estrogen supplements or oral contraceptive pills (for women)
  • Sesame oil allergy

Recruiting US locations

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine

    West Haven, CT 06516

    Site contact: Carly Hewes, BS · (203)932-5711 · carly.hewes@yale.edu

Study contacts (from the official record)

  • Carly Hewes, BS · (203)932-5711 · carly.hewes@yale.edu
Gender Related Differences in the Acute Effects of… (NCT02811510) | Bored Studies